文章摘要
阿柯力江·凯赛尔,刘 正,伊力哈木江,朱 涛,霍 强.急性Stanford A型主动脉夹层患者术后死亡的危险因素及血清NT-proBNP、D-D联合监测对预后的评估价值[J].,2022,(12):2275-2279
急性Stanford A型主动脉夹层患者术后死亡的危险因素及血清NT-proBNP、D-D联合监测对预后的评估价值
Risk Factors of Postoperative Death in Patients with Acute Stanford Type A Aortic Dissection and the Prognostic Value of Serum NT-proBNP and D-D Combined Monitoring
投稿时间:2021-11-26  修订日期:2021-12-22
DOI:10.13241/j.cnki.pmb.2022.12.015
中文关键词: Stanford A型  主动脉夹层  N-末端B型利钠肽原  D-二聚体  危险因素
英文关键词: Stanford type A  Aortic dissection  N-terminal B-type natriuretic peptide  D-dimer  Risk factors
基金项目:新疆维吾尔自治区自然科学基金项目(2016D01C336)
作者单位E-mail
阿柯力江·凯赛尔 新疆医科大学第一附属医院心脏外科 新疆 乌鲁木齐 830011 akexinjiang@163.com 
刘 正 新疆医科大学第一附属医院心脏外科 新疆 乌鲁木齐 830011  
伊力哈木江 新疆医科大学第一附属医院心脏外科 新疆 乌鲁木齐 830011  
朱 涛 新疆医科大学第一附属医院心脏外科 新疆 乌鲁木齐 830011  
霍 强 新疆医科大学第一附属医院心脏外科 新疆 乌鲁木齐 830011  
摘要点击次数: 509
全文下载次数: 220
中文摘要:
      摘要 目的:探讨急性Stanford A型主动脉夹层(ATAAD)患者术后死亡的危险因素,分析血清N-末端B型利钠肽原(NT-proBNP)、D-二聚体(D-D)联合监测在预后评估中的价值。方法:回顾性选择2017年10月至2020年10月我院收治的212例行手术治疗的ATAAD患者,追踪术后30 d生存情况,分为死亡组(36例)和存活组(176例)。收集并比较两组基线、手术和实验室相关资料,多因素Logistic回归分析ATAAD患者术后30 d内死亡的危险因素,受试者工作特征(ROC)曲线分析NT-proBNP、D-D单独及联合预测ATAAD患者术后30 d内死亡的价值。结果:死亡组年龄≥60岁、急性生理与慢性健康状况评估Ⅱ(APACHE Ⅱ)评分、序贯器官功能衰竭(SOFA)评分、血肌酐(Scr)、NT-proBNP、D-D,术前≥2个脏器灌注不良、联合冠脉旁路移植术(CABG)、术后输血、术后并发急性肾损伤、术后并发低心排、持续肾脏替代治疗(CRRT)人数占比,机械通气时间、重症监护病房(ICU)停留时间均高于存活组(P<0.05)。多因素Logistic回归分析显示术前≥2个脏器灌注不良、术后伴急性肾损伤、联合CABG、术后低心排、NT-proBNP、D-D是影响ATAAD患者术后30 d内死亡的危险因素(P<0.05)。NT-proBNP、D-D预测ATAAD患者术后30 d内死亡的曲线下面积为0.728、0.720,联合NT-proBNP和D-D的曲线下面积为0.834,高于单独应用NT-proBNP、D-D。结论:术前脏器灌注不良、术后急性肾损伤、联合CABG手术、术后低心排、NT-proBNP、D-D是影响ATAAD患者住院30d内死亡的危险因素,联合NT-proBNP和D-D在ATAAD患者预后评估有较高价值。
英文摘要:
      ABSTRACT Objective: To discussion the risk factors of postoperative death in patients with acute Stanford type A aortic dissection (ATAAD), and to analyze the value of serum N-terminal B-type natriuretic peptide (NT-proBNP) and D-dimer (D-D) combined monitoring in prognosis assessment. Methods: 212 cases of patients with ATAAD undergoing surgical treatment who were admitted to our hospital from October 2017 to October 2020 were retrospectively selected. and the survival was tracked 30 days after operation, which were divided into death group (36 cases) and survival group (176 cases). Baseline, surgical and laboratory related data were collected and compared between the two groups, and multivariate Logistic regression was used to analyze the risk factors of death within 30 days after operation in patients with ATAAD, and receiver operating characteristic (ROC) curve was used to analyze the value of NT-proBNP and D-D alone and combined in predicting death within 30 days after operation in patients with ATAAD. Results: The age≥60 years, acute physiological and chronic health evaluationⅡ (APACHE Ⅱ) score, sequential organ failure assessment (SOFA) score, blood creatinine (Scr), NT-proBNP, D-D, preoperative≥2 organs had poor perfusion, combined coronary artery bypass grafting (CABG), postoperative blood transfusion, postoperative acute kidney injury, postoperative low cardiac output, continuous renal replacement therapy (CRRT) patients proportion, mechanical ventilation time and intensive care unit (ICU) stay time in death group were higher than those in survival group (P<0.05). Multivariate Logistic regression analysis showed that preoperative≥2 organs had poor perfusion, postoperative acute kidney injury, combined CABG, postoperative low cardiac output, NT-proBNP and D-D were the risk factors affecting the death of patients with ATAAD within 30 days after operation (P<0.05). The area under the curve of NT-proBNP and D-D to predict the death of patients with ATAAD within 30 days after operation was 0.728 and 0.720, and the area under the curve of combined NT-proBNP and D-D was 0.834, which was higher than that of NT-proBNP and D-D alone. Conclusion: Preoperative poor organ perfusion, postoperative acute kidney injury, combined CABG surgery, postoperative low cardiac output, NT-proBNP and D-D are risk factors affecting the death of within 30 days of hospitalization. Combined NT-proBNP and D-D have high value in the prognosis assessment of patients with ATAAD.
查看全文   查看/发表评论  下载PDF阅读器
关闭